[Human papillomavirus and systemic lupus erythematosus]

Area of Science:

• Immunology
• Oncology
• Infectious Diseases

Background:

• Human papillomavirus (HPV) infection is a leading cause of cervical cancer.
• Immunosuppression, common in autoimmune diseases like systemic lupus erythematosus (SLE), may increase susceptibility to HPV infection and cervical dysplasia.
• The specific risks of persistent HPV infection, dysplasia, and cervical cancer in SLE patients are not well-defined.

Purpose of the Study:

• To investigate the risk factors for persistent HPV infection, cervical dysplasia, and cancer in patients with SLE.
• To assess the current understanding of cervical cancer risk in SLE patients compared to the general population.
• To evaluate the need for and barriers to HPV vaccination in SLE patients.

Main Methods:

• Literature review on HPV infection, cervical cancer, and SLE.
• Analysis of existing epidemiological data (if available).
• Discussion of current HPV vaccination recommendations for SLE patients.

Main Results:

• The precise risk factors for HPV-related cervical disease progression in SLE patients remain unidentified.
• The increased risk of cervical cancer in SLE patients compared to the general population is still debated.
• HPV vaccination is recommended for SLE patients, but coverage and barriers are unknown, particularly in France.

Conclusions:

• SLE patients are potentially at higher risk for HPV-related cervical issues.
• Further research is crucial to elucidate these risks and inform clinical management.
• Strategies to improve HPV vaccination uptake in adolescents with chronic conditions like SLE are necessary.